ArticleHuman vaccines & immunotherapeutics2021

Phase 3, open-label, Russian, multicenter, single-arm trial to evaluate the immunogenicity of varicella vaccine (VARIVAX™) in healthy adults.

Erin M Paradis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.